S&P 500   3,317.97 (-1.16%)
DOW   27,668.26 (-0.84%)
QQQ   266.62 (-1.37%)
AAPL   107.80 (-2.30%)
MSFT   199.44 (-1.71%)
FB   253.45 (-0.54%)
GOOGL   1,444.85 (-2.84%)
AMZN   2,941.97 (-2.22%)
NVDA   488.27 (-2.06%)
TSLA   443.90 (+4.83%)
BABA   273.50 (-0.81%)
CGC   16.33 (-0.43%)
GE   6.92 (-1.84%)
MU   50.84 (-0.27%)
AMD   75.07 (-1.93%)
T   28.95 (-0.41%)
F   7.25 (-0.41%)
ACB   6.43 (-6.68%)
GILD   64.97 (-0.11%)
NFLX   465.17 (-1.07%)
DIS   129.45 (-0.59%)
BAC   25.30 (-0.20%)
BA   162.10 (-3.24%)
S&P 500   3,317.97 (-1.16%)
DOW   27,668.26 (-0.84%)
QQQ   266.62 (-1.37%)
AAPL   107.80 (-2.30%)
MSFT   199.44 (-1.71%)
FB   253.45 (-0.54%)
GOOGL   1,444.85 (-2.84%)
AMZN   2,941.97 (-2.22%)
NVDA   488.27 (-2.06%)
TSLA   443.90 (+4.83%)
BABA   273.50 (-0.81%)
CGC   16.33 (-0.43%)
GE   6.92 (-1.84%)
MU   50.84 (-0.27%)
AMD   75.07 (-1.93%)
T   28.95 (-0.41%)
F   7.25 (-0.41%)
ACB   6.43 (-6.68%)
GILD   64.97 (-0.11%)
NFLX   465.17 (-1.07%)
DIS   129.45 (-0.59%)
BAC   25.30 (-0.20%)
BA   162.10 (-3.24%)
S&P 500   3,317.97 (-1.16%)
DOW   27,668.26 (-0.84%)
QQQ   266.62 (-1.37%)
AAPL   107.80 (-2.30%)
MSFT   199.44 (-1.71%)
FB   253.45 (-0.54%)
GOOGL   1,444.85 (-2.84%)
AMZN   2,941.97 (-2.22%)
NVDA   488.27 (-2.06%)
TSLA   443.90 (+4.83%)
BABA   273.50 (-0.81%)
CGC   16.33 (-0.43%)
GE   6.92 (-1.84%)
MU   50.84 (-0.27%)
AMD   75.07 (-1.93%)
T   28.95 (-0.41%)
F   7.25 (-0.41%)
ACB   6.43 (-6.68%)
GILD   64.97 (-0.11%)
NFLX   465.17 (-1.07%)
DIS   129.45 (-0.59%)
BAC   25.30 (-0.20%)
BA   162.10 (-3.24%)
S&P 500   3,317.97 (-1.16%)
DOW   27,668.26 (-0.84%)
QQQ   266.62 (-1.37%)
AAPL   107.80 (-2.30%)
MSFT   199.44 (-1.71%)
FB   253.45 (-0.54%)
GOOGL   1,444.85 (-2.84%)
AMZN   2,941.97 (-2.22%)
NVDA   488.27 (-2.06%)
TSLA   443.90 (+4.83%)
BABA   273.50 (-0.81%)
CGC   16.33 (-0.43%)
GE   6.92 (-1.84%)
MU   50.84 (-0.27%)
AMD   75.07 (-1.93%)
T   28.95 (-0.41%)
F   7.25 (-0.41%)
ACB   6.43 (-6.68%)
GILD   64.97 (-0.11%)
NFLX   465.17 (-1.07%)
DIS   129.45 (-0.59%)
BAC   25.30 (-0.20%)
BA   162.10 (-3.24%)
Log in
NASDAQ:UTHR

United Therapeutics News Headlines

$105.13
-1.54 (-1.44 %)
(As of 09/18/2020 03:06 PM ET)
Add
Compare
Today's Range
$104.31
Now: $105.13
$107.45
50-Day Range
$102.44
MA: $108.16
$116.41
52-Week Range
$75.58
Now: $105.13
$127.79
Volume2,321 shs
Average Volume535,698 shs
Market Capitalization$4.67 billion
P/E Ratio10.79
Dividend YieldN/A
Beta0.74

Headlines

United Therapeutics (NASDAQ UTHR) News Headlines Today

Source:
DateHeadline
United Therapeutics (NASDAQ:UTHR) Now Covered by Analysts at JPMorgan Chase & Co.United Therapeutics (NASDAQ:UTHR) Now Covered by Analysts at JPMorgan Chase & Co.
marketbeat.com - September 14 at 7:34 AM
United Therapeutics (NASDAQ:UTHR) Stock Rating Lowered by BidaskClubUnited Therapeutics (NASDAQ:UTHR) Stock Rating Lowered by BidaskClub
marketbeat.com - August 8 at 8:24 AM
United Therapeutics (NASDAQ:UTHR) Hits New 1-Year High Following Analyst UpgradeUnited Therapeutics (NASDAQ:UTHR) Hits New 1-Year High Following Analyst Upgrade
marketbeat.com - June 25 at 1:19 PM
How Much Did United Therapeutics(NASDAQ:UTHR) Shareholders Earn From Share Price Movements Over The Last Five Years?How Much Did United Therapeutics'(NASDAQ:UTHR) Shareholders Earn From Share Price Movements Over The Last Five Years?
finance.yahoo.com - September 17 at 5:27 PM
How Much Did United Therapeutics'(NASDAQ:UTHR) Shareholders Earn From Share Price Movements Over The Last Five Years?How Much Did United Therapeutics'(NASDAQ:UTHR) Shareholders Earn From Share Price Movements Over The Last Five Years?
finance.yahoo.com - September 17 at 5:27 PM
United Therapeutics to expand RTP campus; iconic building to be demolishedUnited Therapeutics to expand RTP campus; iconic building to be demolished
bizjournals.com - September 15 at 6:29 PM
United Therapeutics (NASDAQ:UTHR) Receives New Coverage from Analysts at JPMorgan Chase & Co.United Therapeutics (NASDAQ:UTHR) Receives New Coverage from Analysts at JPMorgan Chase & Co.
americanbankingnews.com - September 14 at 8:08 AM
United Therapeutics Corporation Appoints Linda Maxwell to Its Board of DirectorsUnited Therapeutics Corporation Appoints Linda Maxwell to Its Board of Directors
finance.yahoo.com - September 11 at 8:33 AM
 Brokerages Anticipate United Therapeutics Co. (NASDAQ:UTHR) to Announce $2.09 EPS Brokerages Anticipate United Therapeutics Co. (NASDAQ:UTHR) to Announce $2.09 EPS
americanbankingnews.com - September 2 at 12:46 PM
United Therapeutics (UTHR) Down 6.9% Since Last Earnings Report: Can It Rebound?United Therapeutics (UTHR) Down 6.9% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - August 28 at 12:52 PM
United Therapeutics Co. (NASDAQ:UTHR) Receives Average Rating of "Hold" from AnalystsUnited Therapeutics Co. (NASDAQ:UTHR) Receives Average Rating of "Hold" from Analysts
americanbankingnews.com - August 27 at 1:29 PM
United Therapeutics Announces FDA Acceptance of Tyvaso sNDAUnited Therapeutics Announces FDA Acceptance of Tyvaso sNDA
finance.yahoo.com - August 18 at 3:14 PM
United Therapeutics Scores FDA Nod For New Tyvaso ReviewUnited Therapeutics Scores FDA Nod For New Tyvaso Review
finance.yahoo.com - August 17 at 12:44 PM
FDA accepts United Therapeutics application for expanded use of TyvasoFDA accepts United Therapeutics application for expanded use of Tyvaso
seekingalpha.com - August 17 at 7:44 AM
United Therapeutics Announces U.S. FDA Filing Acceptance Of Supplemental New Drug Application For Tyvaso® For Pulmonary Hypertension Associated With Interstitial Lung DiseaseUnited Therapeutics Announces U.S. FDA Filing Acceptance Of Supplemental New Drug Application For Tyvaso® For Pulmonary Hypertension Associated With Interstitial Lung Disease
finance.yahoo.com - August 17 at 7:44 AM
United Therapeutics Corporation to Present at the Wedbush PacGrow Healthcare Virtual ConferenceUnited Therapeutics Corporation to Present at the Wedbush PacGrow Healthcare Virtual Conference
finance.yahoo.com - August 5 at 7:34 AM
United Therapeutics (UTHR) Q2 Earnings In Line, Sales BeatUnited Therapeutics (UTHR) Q2 Earnings In Line, Sales Beat
finance.yahoo.com - July 30 at 2:54 PM
United Therapeutics Corporations (NASDAQ:UTHR) Intrinsic Value Is Potentially 73% Above Its Share PriceUnited Therapeutics Corporation's (NASDAQ:UTHR) Intrinsic Value Is Potentially 73% Above Its Share Price
finance.yahoo.com - July 29 at 5:29 PM
Recap: United Therapeutics Q2 EarningsRecap: United Therapeutics Q2 Earnings
finance.yahoo.com - July 29 at 12:29 PM
United Therapeutics (UTHR) Q2 Earnings Meet EstimatesUnited Therapeutics (UTHR) Q2 Earnings Meet Estimates
finance.yahoo.com - July 29 at 12:29 PM
United Therapeutics Corporation's (NASDAQ:UTHR) Intrinsic Value Is Potentially 73% Above Its Share PriceUnited Therapeutics Corporation's (NASDAQ:UTHR) Intrinsic Value Is Potentially 73% Above Its Share Price
finance.yahoo.com - July 29 at 12:29 PM
United Therapeutics EPS beats by $0.41, beats on revenueUnited Therapeutics EPS beats by $0.41, beats on revenue
seekingalpha.com - July 29 at 7:28 AM
United Therapeutics Q2 2020 Earnings PreviewUnited Therapeutics Q2 2020 Earnings Preview
seekingalpha.com - July 28 at 3:31 PM
United Therapeutics sues Liquidia to block Tyvaso competitorUnited Therapeutics sues Liquidia to block Tyvaso competitor
seekingalpha.com - July 23 at 6:52 AM
United Therapeutics Corporation Asserts New Tyvaso Patent Against LiquidiaUnited Therapeutics Corporation Asserts New Tyvaso Patent Against Liquidia
finance.yahoo.com - July 23 at 6:52 AM
What can we use to predict NSQ:UTHRs share price direction?What can we use to predict NSQ:UTHR's share price direction?
uk.finance.yahoo.com - July 22 at 11:16 PM
United Therapeutics (UTHR) Expected to Beat Earnings Estimates: Should You Buy?United Therapeutics (UTHR) Expected to Beat Earnings Estimates: Should You Buy?
finance.yahoo.com - July 22 at 1:14 PM
United Therapeutics Corporation To Report Second Quarter 2020 Financial Results Before The Market Opens On Wednesday, July 29, 2020United Therapeutics Corporation To Report Second Quarter 2020 Financial Results Before The Market Opens On Wednesday, July 29, 2020
finance.yahoo.com - July 22 at 8:14 AM
Did Hedge Funds Make The Right Call On United Therapeutics Corporation (UTHR)Did Hedge Funds Make The Right Call On United Therapeutics Corporation (UTHR)
finance.yahoo.com - July 13 at 8:25 PM
United Therapeutics Corp.United Therapeutics Corp.
www.marketwatch.com - July 10 at 12:35 AM
Is the United Therapeutics share price too low?Is the United Therapeutics share price too low?
uk.finance.yahoo.com - July 6 at 8:51 AM
3 Health Care Companies That Beat the Market in the 1st Half of the Year3 Health Care Companies That Beat the Market in the 1st Half of the Year
finance.yahoo.com - June 30 at 6:22 PM
United Therapeutics extends Lilly Adcirca deal three yearsUnited Therapeutics extends Lilly Adcirca deal three years
seekingalpha.com - June 29 at 9:41 AM
First Week of UTHR February 2021 Options TradingFirst Week of UTHR February 2021 Options Trading
www.nasdaq.com - June 26 at 1:36 PM
Disentangling the effect of Covid-19 on United Therapeuticss share priceDisentangling the effect of Covid-19 on United Therapeutics's share price
uk.finance.yahoo.com - June 19 at 7:57 AM
Can United Therapeutics ride out the economic uncertainty?Can United Therapeutics ride out the economic uncertainty?
uk.finance.yahoo.com - June 18 at 11:03 PM
Why United Therapeutics (NSQ:UTHR) could be a stock to watchWhy United Therapeutics (NSQ:UTHR) could be a stock to watch
uk.finance.yahoo.com - June 18 at 11:03 PM
United Therapeutics Announces Increase Data Presentation at an American Thoracic Society Virtual SessionUnited Therapeutics Announces Increase Data Presentation at an American Thoracic Society Virtual Session
finance.yahoo.com - June 17 at 9:58 AM
MannKind: Stone Age Technology Isnt A Solution For Modern Day Medical NeedsMannKind: Stone Age Technology Isn't A Solution For Modern Day Medical Needs
seekingalpha.com - June 13 at 9:13 AM
This Bullish Option Trade In United Therapeutics Stock Offers Potential 38.9% ReturnThis Bullish Option Trade In United Therapeutics Stock Offers Potential 38.9% Return
finance.yahoo.com - June 9 at 7:52 PM
Vertex CEO Provided Best Value for InvestorsVertex CEO Provided Best Value for Investors
finance.yahoo.com - June 8 at 1:16 PM
United Therapeutics sues North Carolina competitor for patent infringementUnited Therapeutics sues North Carolina competitor for patent infringement
www.bizjournals.com - June 5 at 8:04 PM
Should You Avoid United Therapeutics Corporation (UTHR)?Should You Avoid United Therapeutics Corporation (UTHR)?
finance.yahoo.com - June 5 at 3:04 PM
United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso PatentsUnited Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso Patents
finance.yahoo.com - June 5 at 9:59 AM
Why quality and value could drive the United Therapeutics share price higherWhy quality and value could drive the United Therapeutics share price higher
uk.finance.yahoo.com - June 4 at 12:44 AM
Why Is United Therapeutics (UTHR) Up 5% Since Last Earnings Report?Why Is United Therapeutics (UTHR) Up 5% Since Last Earnings Report?
finance.yahoo.com - June 1 at 9:35 AM
United Therapeutics (UTHR) Presents At Bank of America Healthcare Virtual Conference 2020 - SlideshowUnited Therapeutics (UTHR) Presents At Bank of America Healthcare Virtual Conference 2020 - Slideshow
seekingalpha.com - May 14 at 4:43 PM
United Therapeutics Corporation To Present At The BofA Securities Virtual Health Care Conference 2020United Therapeutics Corporation To Present At The BofA Securities Virtual Health Care Conference 2020
finance.yahoo.com - May 6 at 6:44 AM
Has United Therapeutics Corporations (NASDAQ:UTHR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?Has United Therapeutics Corporation's (NASDAQ:UTHR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
finance.yahoo.com - May 5 at 10:32 AM
Has United Therapeutics Corporation's (NASDAQ:UTHR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?Has United Therapeutics Corporation's (NASDAQ:UTHR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
finance.yahoo.com - May 4 at 5:41 PM
Can United Therapeutics ride out the Covid-19 economic shock?Can United Therapeutics ride out the Covid-19 economic shock?
uk.finance.yahoo.com - May 4 at 7:38 AM
United Therapeutics (UTHR) is a Great Momentum Stock: Should You Buy?United Therapeutics (UTHR) is a Great Momentum Stock: Should You Buy?
finance.yahoo.com - May 1 at 4:53 PM
Edited Transcript of UTHR earnings conference call or presentation 29-Apr-20 1:00pm GMTEdited Transcript of UTHR earnings conference call or presentation 29-Apr-20 1:00pm GMT
finance.yahoo.com - April 30 at 4:32 AM
This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.